Sabra Health Care REIT (NASDAQ:SBRA) Price Target Raised to $18.00 at Truist Financial

Sabra Health Care REIT (NASDAQ:SBRA) had its price target hoisted by investment analysts at Truist Financial from $17.00 to $18.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s target price would indicate a potential upside of 2.21% from the company’s previous close.

Other equities analysts have also recently issued reports about the company. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. Mizuho restated a “neutral” rating and set a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Finally, JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research note on Tuesday, January 7th. Three analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Sabra Health Care REIT currently has a consensus rating of “Moderate Buy” and a consensus price target of $19.33.

Sabra Health Care REIT Stock Performance

Sabra Health Care REIT stock opened at $17.61 on Tuesday. The stock has a market cap of $4.19 billion, a P/E ratio of 33.23, a price-to-earnings-growth ratio of 1.97 and a beta of 1.27. The company has a current ratio of 4.32, a quick ratio of 4.16 and a debt-to-equity ratio of 0.88. The stock has a 50 day moving average of $16.77 and a 200-day moving average of $17.67. Sabra Health Care REIT has a 52 week low of $13.31 and a 52 week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The firm had revenue of $182.35 million for the quarter, compared to analysts’ expectations of $178.01 million. On average, analysts expect that Sabra Health Care REIT will post 1.45 EPS for the current fiscal year.

Institutional Investors Weigh In On Sabra Health Care REIT

A number of hedge funds have recently added to or reduced their stakes in SBRA. VSM Wealth Advisory LLC bought a new stake in Sabra Health Care REIT in the fourth quarter valued at $26,000. Quarry LP acquired a new position in shares of Sabra Health Care REIT during the third quarter valued at $30,000. Assetmark Inc. increased its holdings in shares of Sabra Health Care REIT by 168.4% during the third quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust’s stock valued at $37,000 after purchasing an additional 1,231 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in shares of Sabra Health Care REIT during the third quarter valued at $59,000. Finally, GF Fund Management CO. LTD. acquired a new position in shares of Sabra Health Care REIT during the fourth quarter valued at $74,000. 99.40% of the stock is currently owned by institutional investors.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.